MDS Past President, Oscar S Gershanik (Favaloro Foundation University Hospital, Buenos Aires, Argentina) talked to us about dyskinesia in Parkinson’s disease, the topic of one of the plenary sessions he participated in during the congress.
Questions
1. What is the prevalence of levodopa-induced dyskinesias? (0:05)
2. What factors affect the development of dyskinesias? (0:44)
3. Could you give us a brief overview of the different types of dyskinesias? (1:56)
4. What are the major challenges in the clinical recognition of dyskinesia? (3:46)
5. What is the impact of levodopa-induced dyskinesias on health care utilisation? (4:52)
Speaker disclosure: Oscar S Gershanik has nothing relevant to disclose in relation to this video interview.
Filmed at the International Congress of Parkinson’s Disease and Movement Disorders (MDS), Nice, France, September 2019.
